| LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 |
901 NEW YORK AVENUE, NW
| Address2 |
Suite 510 E
|
| City |
WASHINGTON
| State |
DC
| Zip Code |
20001
| Country |
USA
|
3. Principal place of business (if different than line 2)
| City |
Irving
| State |
TX
| Zip Code |
75039
| Country |
USA
|
| 5. Senate ID# 40021-00012
|
||||||||
| 6. House ID# 313240000
|
||||||||
| TYPE OF REPORT | 8. Year |
2011
| Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
| 11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
| Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature |
Digitally Signed By: Michael J. Regier
| Date |
07/15/2011
|
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Accountable Care Organizations - tracked the release of regulations establishing the Medicare Shared Savings Program and similar efforts through the Center for Medicare and Medicaid Innovations. Advocated for a flexible approach that would allow hospitals greater opportunities to develop ACOs and share in savings generated through care coordination.
House Budget Resolution - monitored proposals that would move the traditional Medicare program to a premium-support model and shift Medicaid funding to block-grants in place of traditional state matching funding.
Deficit Reduction Efforts - tracked various proposals from the House and Senate aimed at reducing the deficit. Opposed efforts to reduce hospital payments.
Independent Payment Advisory Board (S. 668, H.R. 452) - Supported legislation that would repeal the Independent Payment Advisory Board.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Hospital Group Purchasing - conducted education and outreach on value of hospital group purchasing organizations. Advocated in support of proposals that would provide greater transparency in the pricing of medical devices.
Partnership for Patients - engaged in efforts to support that national patient safety initiative and endorsed the efforts to improve
patient safety.
Health Care Information Technology - opposed regulations stemming from the HITECH Act that would require cumbersome accounting for disclosure requirements.
S. 296 - monitored legislation that would require drug manufacturers to report to the FDA on potential drug shortages.
Unique Device Identification - advocated for the release of regulations from the FDA establishing a unique device identification system as required under the Food and Drug Administration Amendments Act of 2007.
340B (of the Public Health Services Act) Drug Pricing Program - Monitored proposals to expand the 340B program to inpatient hospitals.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Not-For-Profit Hospital Tax Exemption - Monitored efforts to expand tax-exempt hospital reporting obligations stemming from the passage of the Patient Protection and Affordable Care Act. Tracked IRS proposals requiring expanded reporting on the IRS Form 990 Schedule H and advocated for policies that would not increase the reporting burden for hospitals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
| State |
| Zip Code |
| Country |
|
21. Client new principal place of business (if different than line 20)
| City |
| State |
| Zip Code |
| Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
| 3 |
|
||||||
| 2 |
| 4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address | Principal place of business (city and state or country) | Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
|
||||||||||||||
|
|
| % | ||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |